Bioengineering Approaches to Female Infertility

Pamela Kreeger^*
*Correspondence: Pamela Kreeger, Department of Cell and Regenerative Biology, University of Wisconsin School of Medicine and Public Health, Wisconsin 53705, USA, Email:

Keywords

Nanomaterials • Diagnostics • Healthcare • Three-dimensional matrices

Introduction

For clinical applications, the biologically functional design of metal implants is very important. Effective methods for human tissue repair and regeneration are provided by novel metal implants with various biological functions. The most intriguing issues in biomedical engineering concern innovative metal implant design and application. Three well-known biological designs and their applications for metal implants were examined in this paper. It is divided into three main sections: the first describes the biomechanical design of metal implants, followed by the design of porous structures and the biological activation of metal implants. Finally, the biodegradable design of metal implants is discussed as a new regenerative engineering trend. The most recent developments in biodegradable metals and how they can be used in orthopedic and cardiovascular implants are discussed. The goal for metallic implants in the future is to combine bio-functionality and a suitable mechanical property. One of the most intriguing areas of biomaterials research is the investigation of novel metallic implants [1].

Description

However, biomedical applications, such as tissue engineering, cartilage replacement, bone repair, medical implants and wound dressings, which have received exponentially more attention in the past ten years, emerged as a particularly appealing field. Again, in the biomedical field, nanocellulose has also been looked into as a way to deliver drugs in recent years. The majority of research on this subject has focused on drug adsorption onto the nanocrystal surface, which accounts for the low number of publications. However, the use of nanocellulose and other potential nanoparticles has recently been demonstrated to have certain advantages and research in this area is gaining attention [2].

To precisely match the non-linear stress-strain responses of human skin at various locations (such as the back and abdomen), the network design can be implemented in a sandwich construction (Silbione/filamentary network/ Silbione). As saved on a glass slide to act as a conciliatory layer, trailed by turn projecting of a PI layer onto the highest point of the copper layer. This PI layer can be photolithographically patterned into a deterministic network that was transfer printed onto the elastomer's surface and uniformly coated with another elastomer layer. Move printing of the stretchable gadgets onto this composite, strain-restricting construction completes the reconciliation of the whole gadget framework [3]. This kind of network design's ability to limit strain can also be used to protect electronic components from stretching that could cause them to break.

By combining low toxicity with the absence of antivector immunity, subunit vaccines utilizing recombinant protein or polysaccharide antigens and molecular adjuvants via synthetic delivery systems may be appealing alternatives to live viral or bacterial vaccines. New biomaterials, particularly nanomaterials, that can carry both antigen and adjuvant, protect them from degradation in vivo and deliver them to targeted lymphoid tissues, such as LNs and mucosa-associated lymphoid tissues (e.g., lymphoid organs of the airways, gastrointestinal tract and reproductive tract), have made rapid progress in design and synthesis [4].

The thymus and bone marrow are the primary lymphoid organs that produce immune system cells, while the spleen, LNs and Peyer's patches are the secondary lymphoid organs that keep or activate those cells. Biomaterials have been looked at as platforms for making functional lymphoid tissues in vitro and as scaffolds for making synthetic lymphoid organs in vivo, just like in other regenerative medicine applications. In humanized mouse models, where the native murine lymphoid tissue exhibits structural or organizational defects due to the immunodeficient background of the animals during development as well as incomplete crosstalk between mouse and human cytokines and receptors, synthetic lymphoid organs can be used as platforms to dissect crucial cues in lymphoid tissue organogenesis or neogenesis. In addition to serving as a screening tool for the development of vaccines or drugs, in vitro models of lymphoid tissue could serve as an important nonanimal model-based solution to preclinical toxicity testing of pharmaceutical agents.

Cells are immersed in a complex environment of biochemical and biophysical cues in their natural setting. The cellular behaviors of adhesion, migration, apoptosis and differentiation are controlled by these cues, which can include growth factors, the extracellular matrix, cell–cell contacts, stiffness and topography [5]. The decision-making process that is used to turn these extracellular inputs into actions is extremely complicated and sensitive to changes in both the type of individual cue (like growth factor dose/level, timing) and the way these individual cues are combined (like homotypic and heterotypic combinations). In this review, we talk about recent developments in engineering-based methods for studying how cells make decisions. In particular, we talk about the application of computational modeling to analyses of the intricate cellular decision-making networks and the use of biomaterial platforms to control and tailor the delivery of individual and combined cues.

Conclusion

Many biomedical engineers want to use what we know about cellular decision-making to control these decisions in the direction of a desired outcome, like wound healing or tissue regeneration. Achieving a desired outcome necessitates figuring out how to best tip the balance of cellular decisions toward the ultimate goal, as single-cell experiments have demonstrated that even for uniform stimuli, there is significant heterogeneity with respect to an individual cellular decision and that cells can execute multiple decisions in response to a single cue.

Acknowledgement

None.

Conflict of Interest

There are no conflicts of interest by author.

References

1. Rodrigues, Melanie, Harry Blair, Linda Stockdale and Linda Griffith, et al. "Surface tethered epidermal growth factor protects proliferating and differentiating multipotential stromal cells from FasL-induced apoptosis." Stem Cells 31 (2013): 104-116.

Google Scholar, Crossref, Indexed at

2. Nuschke, Austin, Melanie Rodrigues, Jaime Rivera and Cecelia Yates, et al. "Epidermal growth factor tethered to β-tricalcium phosphate bone scaffolds via a high-affinity binding peptide enhances survival of human mesenchymal stem cells/multipotent stromal cells in an immune-competent parafascial implantation assay in mice." Stem Cells Transl Med 5 (2016): 1580-1586.

Google Scholar, Crossref, Indexed at

3. McCall, Joshua D. and Kristi S. Anseth. "Thiol–ene photopolymerizations provide a facile method to encapsulate proteins and maintain their bioactivity." Biomacromolecules 13 (2012): 2410-2417.

Google Scholar, Crossref, Indexed at

4. Anderson, Sean M., Tom T. Chen, M. Luisa Iruela-Arispe and Tatiana Segura, et al. "The phosphorylation of vascular endothelial growth factor receptor-2 (VEGFR-2) by engineered surfaces with electrostatically or covalently immobilized VEGF." Biomaterials 30 (2009): 4618-4628.

Google Scholar, Crossref, Indexed at

5. Kim, Chloe S., Isaiah P. Mitchell, Anthony W. Desotell and Pamela K. Kreeger, et al. "Immobilized epidermal growth factor stimulates persistent, directed keratinocyte migration via activation of PLCγ1." Faseb J 30 (2016): 2580-2590.

Google Scholar, Crossref, Indexed at